ghk cu peptide serum for face dihexa oral brain Therapy: & Memory Support dihexa peptide dihexa injection – Dihexa (PNB-0408) — Dosing, Side – Dihexa Peptide Therapy Boynton Beach

et al., 2014)

Perfekt fr vuxna som sker terhmtningsstd, ledhlsa eller inflammationshantering

Stable gastric pentadecapeptide BPC 157 in the therapy of the rats with bile duct ligation

Each year, an estimated 300,000 adults in the United States die of causes related to obesity [2] According to the guidelines of the National Institute of Health (NIH) regarding the treatment of obesity, weight loss drugs approved by the FDA [US Food and Drug Administration] may only be used as part of a comprehensive weight loss program, including dietary therapy and physical activity, for patients with a BMI [body mass index] of 30 with no concomitant obesity-related risk factors or diseases, and for patients with a BMI of 27 with concomitant obesity-related risk factors or diseases[3].The risk factors and diseases considered important enough to warrant pharmacotherapy at a BMI of 27--29.9 are hypertension, dyslipidemia, coronary heart disease (CHD), type 2 diabetes, and sleep apnea [3]

Contact Us to schedule a consultation